Bio & Pharmaceuticals

DE: Datwyler to Invest $102M+, Hire 120 for New U.S. Plant

6 Oct, 2016

Datwyler is strengthening its position in the U.S., the world's largest pharmaceutical market: the company is channeling more than $102 million into building a new plant in Delaware, which will be used to manufacture high-quality elastomer components for injectable drug delivery systems. The new, highly automated facility in the U.S. meets the most stringent quality standards. 

Datwyler is investing in further expanding its production capacity for high-quality elastomer components for injectable drug delivery systems. The company is planning to spend more than $102 million on building a new plant in Delaware, with construction work likely to get under way before the end of 2016. Production is scheduled to start in the first half of 2018. Once it is fully up and running, Datwyler's new, highly automated plant in the U.S. will provide jobs for around 120 employees.

Strengthening Datwyler's position in the Key U.S. Pharmaceutical Market
Datwyler, which has been operating its own plant in the U.S. since 1981, is a supplier to America's leading health care and pharmaceutical providers. With its new production site in Delaware, the company will be able to significantly boost its position in the world's largest pharmaceutical market. The new plant is to be designed, built and run in accordance with Datwyler's latest "FirstLine" standards. This will make it possible to provide customers in the three key business regions of the U.S., Europe and Asia with locally produced first-line components in future.

"FirstLine" Standards for High-Quality Elastomer Components
The "FirstLine" standards comprise a manufacturing concept for high-quality elastomer components based on ultra-modern clean room technology, automated production cells, fully automated camera inspection and a unique washing process. This innovative approach to manufacturing exceeds the most stringent quality standards of the European and U.S. regulatory authorities and is certified to ISO 15378.

Datwyler Group (
The Datwyler Group is a focused industrial supplier with leading positions in global and regional market segments. With its technological leadership and customized solutions, the Group delivers added value to customers in the markets served. Datwyler concentrates on markets that offer opportunities to create more value and sustain profitable growth. The Technical Components division is one of Europe's foremost high-service distributors of electronic, ICT and automation components and accessories. The Sealing Solutions division is a leading supplier of custom sealing solutions to global market segments, such as the health care, automotive, civil engineering and consumer goods industries. With a total of more than 50 operating companies, sales in over 100 countries and some 7,000 employees, the Datwyler Group generates annual revenue of some CHF 1,200 million. The Group has been listed on the SIX Swiss Exchange since 1986 (security number 3048677).